PS
BIO icon

Principal Securities’s Bio-Rad Laboratories Class A BIO Stock Holding History

Principal Securities’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.22M Buy
4,385
+113
+3% +$32.5K 0.02% 656
2025
Q4 		$1.29M Buy
4,272
+1,273
+42% +$397K 0.02% 625
2025
Q3 		$841K Buy
2,999
+69
+2% +$18.8K 0.01% 723
2025
Q2 		$707K Sell
2,930
-64
-2% -$15.1K 0.01% 719
2025
Q1 		$984K Hold
2,994
– – 0.02% 560
2024
Q4 		$984K Buy
2,994
+2,807
+1,501% +$953K 0.02% 556
2024
Q3 		$62.6K Buy
187
+1
+0.5% +$318 ﹤0.01% 1594
2024
Q2 		$50.8K Buy
186
+17
+10% +$4.94K ﹤0.01% 1617
2024
Q1 		$58.5K Buy
169
+41
+32% +$13.5K ﹤0.01% 1500
2023
Q4 		$41.3K Buy
+128
New +$40.1K ﹤0.01% 1571

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return